Cushing's Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat.

ABSTRACT: Cushing's syndrome (CS), secondary to paraneoplastic syndrome, is more commonly seen in small cell lung cancer but never before reported in epidermal growth factor receptor-mutated adenocarcinoma of the lung. Here, we present a case of a patient whose symptoms of hypokalemia, hypertension, and progressive abnormal glucose levels led to further workup that revealed adrenocorticotropic hormone-dependent hypercortisolism. Her cortisol levels dropped after 1 month of osilodrostat treatment, while lung cancer was treated with osimertinib. The use of osilodrostat in paraneoplastic CS has been previously reported in only 3 patients.

SUBMITTER: Heleno CT 

PROVIDER: S-EPMC9978924 | biostudies-literature | 2023 Jan-Dec

REPOSITORIES: biostudies-literature